位置:首页 > 蛋白库 > ELL3_HUMAN
ELL3_HUMAN
ID   ELL3_HUMAN              Reviewed;         397 AA.
AC   Q9HB65; B3KQ66; B3KX08; Q6I9Z7; Q9H634;
DT   07-JUN-2004, integrated into UniProtKB/Swiss-Prot.
DT   07-JUN-2004, sequence version 2.
DT   03-AUG-2022, entry version 150.
DE   RecName: Full=RNA polymerase II elongation factor ELL3;
GN   Name=ELL3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000312|EMBL:AAG13463.1};
RN   [1] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, SUBCELLULAR LOCATION, AND
RP   TISSUE SPECIFICITY.
RX   PubMed=10882741; DOI=10.1074/jbc.m005175200;
RA   Miller T., Williams K., Johnstone R.W., Shilatifard A.;
RT   "Identification, cloning, expression, and biochemical characterization of
RT   the testis-specific RNA polymerase II elongation factor ELL3.";
RL   J. Biol. Chem. 275:32052-32056(2000).
RN   [2] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Small intestine {ECO:0000312|EMBL:BAB15432.1}, Testis, and Uterus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16572171; DOI=10.1038/nature04601;
RA   Zody M.C., Garber M., Sharpe T., Young S.K., Rowen L., O'Neill K.,
RA   Whittaker C.A., Kamal M., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Kodira C.D., Madan A., Qin S., Yang X., Abbasi N.,
RA   Abouelleil A., Arachchi H.M., Baradarani L., Birditt B., Bloom S.,
RA   Bloom T., Borowsky M.L., Burke J., Butler J., Cook A., DeArellano K.,
RA   DeCaprio D., Dorris L. III, Dors M., Eichler E.E., Engels R., Fahey J.,
RA   Fleetwood P., Friedman C., Gearin G., Hall J.L., Hensley G., Johnson E.,
RA   Jones C., Kamat A., Kaur A., Locke D.P., Madan A., Munson G., Jaffe D.B.,
RA   Lui A., Macdonald P., Mauceli E., Naylor J.W., Nesbitt R., Nicol R.,
RA   O'Leary S.B., Ratcliffe A., Rounsley S., She X., Sneddon K.M.B.,
RA   Stewart S., Sougnez C., Stone S.M., Topham K., Vincent D., Wang S.,
RA   Zimmer A.R., Birren B.W., Hood L., Lander E.S., Nusbaum C.;
RT   "Analysis of the DNA sequence and duplication history of human chromosome
RT   15.";
RL   Nature 440:671-675(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lung {ECO:0000312|EMBL:AAH19293.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   FUNCTION, IDENTIFICATION IN THE SEC COMPLEX, AND IDENTIFICATION IN THE LEC
RP   COMPLEX.
RX   PubMed=22195968; DOI=10.1016/j.molcel.2011.12.008;
RA   Smith E.R., Lin C., Garrett A.S., Thornton J., Mohaghegh N., Hu D.,
RA   Jackson J., Saraf A., Swanson S.K., Seidel C., Florens L., Washburn M.P.,
RA   Eissenberg J.C., Shilatifard A.;
RT   "The little elongation complex regulates small nuclear RNA transcription.";
RL   Mol. Cell 44:954-965(2011).
RN   [8]
RP   REVIEW ON THE SUPER ELONGATION COMPLEX.
RX   PubMed=22895430; DOI=10.1038/nrm3417;
RA   Luo Z., Lin C., Shilatifard A.;
RT   "The super elongation complex (SEC) family in transcriptional control.";
RL   Nat. Rev. Mol. Cell Biol. 13:543-547(2012).
CC   -!- FUNCTION: Enhancer-binding elongation factor that specifically binds
CC       enhancers in embryonic stem cells (ES cells), marks them, and is
CC       required for their future activation during stem cell specification.
CC       Does not only bind to enhancer regions of active genes, but also marks
CC       the enhancers that are in a poised or inactive state in ES cells and is
CC       required for establishing proper RNA polymerase II occupancy at
CC       developmentally regulated genes in a cohesin-dependent manner. Probably
CC       required for priming developmentally regulated genes for later
CC       recruitment of the super elongation complex (SEC), for transcriptional
CC       activation during differentiation. Required for recruitment of P-TEFb
CC       within SEC during differentiation. Probably preloaded on germ cell
CC       chromatin, suggesting that it may prime gene activation by marking
CC       enhancers as early as in the germ cells. Promoting epithelial-
CC       mesenchymal transition (EMT) (By similarity). Elongation factor
CC       component of the super elongation complex (SEC), a complex required to
CC       increase the catalytic rate of RNA polymerase II transcription by
CC       suppressing transient pausing by the polymerase at multiple sites along
CC       the DNA. Component of the little elongation complex (LEC), a complex
CC       required to regulate small nuclear RNA (snRNA) gene transcription by
CC       RNA polymerase II and III (PubMed:22195968). {ECO:0000250,
CC       ECO:0000269|PubMed:10882741, ECO:0000269|PubMed:22195968}.
CC   -!- SUBUNIT: Interacts with AFF4 (By similarity). Component of the super
CC       elongation complex (SEC), at least composed of EAF1, EAF2, CDK9,
CC       MLLT3/AF9, AFF (AFF1 or AFF4), the P-TEFb complex and ELL (ELL, ELL2 or
CC       ELL3). Component of the little elongation complex (LEC), at least
CC       composed of ELL (ELL, ELL2 or ELL3), ZC3H8, ICE1 and ICE2.
CC       {ECO:0000250, ECO:0000269|PubMed:22195968}.
CC   -!- INTERACTION:
CC       Q9HB65; Q96JC9: EAF1; NbExp=5; IntAct=EBI-715224, EBI-769261;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10882741}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9HB65-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9HB65-2; Sequence=VSP_045937;
CC   -!- TISSUE SPECIFICITY: Testis specific. {ECO:0000269|PubMed:10882741}.
CC   -!- SIMILARITY: Belongs to the ELL/occludin family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF276512; AAG13463.1; -; mRNA.
DR   EMBL; AK026290; BAB15432.1; -; mRNA.
DR   EMBL; AK057528; BAG51928.1; -; mRNA.
DR   EMBL; AK126384; BAG54320.1; -; mRNA.
DR   EMBL; CR457358; CAG33639.1; -; mRNA.
DR   EMBL; AC018512; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471082; EAW77238.1; -; Genomic_DNA.
DR   EMBL; BC006548; AAH06548.1; -; mRNA.
DR   EMBL; BC019293; AAH19293.1; -; mRNA.
DR   CCDS; CCDS10102.1; -. [Q9HB65-1]
DR   RefSeq; NP_079441.1; NM_025165.2. [Q9HB65-1]
DR   AlphaFoldDB; Q9HB65; -.
DR   SMR; Q9HB65; -.
DR   BioGRID; 123198; 23.
DR   CORUM; Q9HB65; -.
DR   IntAct; Q9HB65; 19.
DR   STRING; 9606.ENSP00000320346; -.
DR   iPTMnet; Q9HB65; -.
DR   PhosphoSitePlus; Q9HB65; -.
DR   BioMuta; ELL3; -.
DR   DMDM; 48428154; -.
DR   EPD; Q9HB65; -.
DR   jPOST; Q9HB65; -.
DR   MassIVE; Q9HB65; -.
DR   MaxQB; Q9HB65; -.
DR   PaxDb; Q9HB65; -.
DR   PeptideAtlas; Q9HB65; -.
DR   PRIDE; Q9HB65; -.
DR   ProteomicsDB; 81498; -. [Q9HB65-1]
DR   Antibodypedia; 24110; 128 antibodies from 21 providers.
DR   DNASU; 80237; -.
DR   Ensembl; ENST00000319359.8; ENSP00000320346.3; ENSG00000128886.12. [Q9HB65-1]
DR   GeneID; 80237; -.
DR   KEGG; hsa:80237; -.
DR   MANE-Select; ENST00000319359.8; ENSP00000320346.3; NM_025165.3; NP_079441.1.
DR   UCSC; uc001zsw.2; human. [Q9HB65-1]
DR   CTD; 80237; -.
DR   DisGeNET; 80237; -.
DR   GeneCards; ELL3; -.
DR   HGNC; HGNC:23113; ELL3.
DR   HPA; ENSG00000128886; Tissue enhanced (lymphoid tissue, skin).
DR   MIM; 609885; gene.
DR   neXtProt; NX_Q9HB65; -.
DR   PharmGKB; PA128394728; -.
DR   VEuPathDB; HostDB:ENSG00000128886; -.
DR   eggNOG; KOG4796; Eukaryota.
DR   GeneTree; ENSGT00940000161615; -.
DR   HOGENOM; CLU_692530_0_0_1; -.
DR   InParanoid; Q9HB65; -.
DR   OMA; RLHCLGP; -.
DR   OrthoDB; 335949at2759; -.
DR   PhylomeDB; Q9HB65; -.
DR   TreeFam; TF337345; -.
DR   PathwayCommons; Q9HB65; -.
DR   Reactome; R-HSA-6807505; RNA polymerase II transcribes snRNA genes.
DR   SignaLink; Q9HB65; -.
DR   BioGRID-ORCS; 80237; 25 hits in 1081 CRISPR screens.
DR   GenomeRNAi; 80237; -.
DR   Pharos; Q9HB65; Tbio.
DR   PRO; PR:Q9HB65; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   RNAct; Q9HB65; protein.
DR   Bgee; ENSG00000128886; Expressed in duodenum and 97 other tissues.
DR   ExpressionAtlas; Q9HB65; baseline and differential.
DR   Genevisible; Q9HB65; HS.
DR   GO; GO:0030054; C:cell junction; IDA:HPA.
DR   GO; GO:0005694; C:chromosome; IDA:HPA.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0016607; C:nuclear speck; IDA:HPA.
DR   GO; GO:0005730; C:nucleolus; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0008023; C:transcription elongation factor complex; IDA:UniProtKB.
DR   GO; GO:0000987; F:cis-regulatory region sequence-specific DNA binding; ISS:UniProtKB.
DR   GO; GO:0006354; P:DNA-templated transcription, elongation; IDA:UniProtKB.
DR   GO; GO:0042771; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; IEA:Ensembl.
DR   GO; GO:1902166; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; IEA:Ensembl.
DR   GO; GO:0061351; P:neural precursor cell proliferation; IEA:Ensembl.
DR   GO; GO:0032786; P:positive regulation of DNA-templated transcription, elongation; IDA:UniProtKB.
DR   GO; GO:2000179; P:positive regulation of neural precursor cell proliferation; IEA:Ensembl.
DR   GO; GO:0050769; P:positive regulation of neurogenesis; IEA:Ensembl.
DR   GO; GO:2000648; P:positive regulation of stem cell proliferation; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:UniProtKB.
DR   GO; GO:0032968; P:positive regulation of transcription elongation from RNA polymerase II promoter; IBA:GO_Central.
DR   GO; GO:0010717; P:regulation of epithelial to mesenchymal transition; ISS:UniProtKB.
DR   GO; GO:0042795; P:snRNA transcription by RNA polymerase II; IMP:UniProtKB.
DR   GO; GO:0007283; P:spermatogenesis; NAS:UniProtKB.
DR   GO; GO:0048863; P:stem cell differentiation; ISS:UniProtKB.
DR   GO; GO:0072089; P:stem cell proliferation; IEA:Ensembl.
DR   GO; GO:0006366; P:transcription by RNA polymerase II; ISS:UniProtKB.
DR   GO; GO:0006368; P:transcription elongation from RNA polymerase II promoter; IDA:UniProtKB.
DR   InterPro; IPR031176; ELL/occludin.
DR   InterPro; IPR031175; ELL3.
DR   InterPro; IPR019464; ELL_N.
DR   InterPro; IPR010844; Occludin_ELL.
DR   PANTHER; PTHR23288; PTHR23288; 1.
DR   PANTHER; PTHR23288:SF18; PTHR23288:SF18; 1.
DR   Pfam; PF10390; ELL; 1.
DR   Pfam; PF07303; Occludin_ELL; 1.
DR   PROSITE; PS51980; OCEL; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Nucleus; Reference proteome; Transcription;
KW   Transcription regulation.
FT   CHAIN           1..397
FT                   /note="RNA polymerase II elongation factor ELL3"
FT                   /id="PRO_0000146736"
FT   DOMAIN          285..395
FT                   /note="OCEL"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01324"
FT   REGION          164..219
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          237..284
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        165..181
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        190..204
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   VAR_SEQ         1..56
FT                   /note="MEELQEPLRGQLRLCFTQAARTSLLLLRLNDAALRALQECQRQQVRPVIAFQ
FT                   GHRG -> MGLTVSFHPQ (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_045937"
FT   VARIANT         11
FT                   /note="Q -> E (in dbSNP:rs2277531)"
FT                   /id="VAR_018992"
FT   VARIANT         140
FT                   /note="W -> R (in dbSNP:rs35454865)"
FT                   /id="VAR_053074"
FT   CONFLICT        5
FT                   /note="Q -> H (in Ref. 1; AAG13463)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        278
FT                   /note="S -> P (in Ref. 2; BAG54320)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   397 AA;  45361 MW;  9DC16B3D6E184FA7 CRC64;
     MEELQEPLRG QLRLCFTQAA RTSLLLLRLN DAALRALQEC QRQQVRPVIA FQGHRGYLRL
     PGPGWSCLFS FIVSQCCQEG AGGSLDLVCQ RFLRSGPNSL HCLGSLRERL IIWAAMDSIP
     APSSVQGHNL TEDARHPESW QNTGGYSEGD AVSQPQMALE EVSVSDPLAS NQGQSLPGSS
     REHMAQWEVR SQTHVPNREP VQALPSSASR KRLDKKRSVP VATVELEEKR FRTLPLVPSP
     LQGLTNQDLQ EGEDWEQEDE DMDPRLEHSS SVQEDSESPS PEDIPDYLLQ YRAIHSAEQQ
     HAYEQDFETD YAEYRILHAR VGTASQRFIE LGAEIKRVRR GTPEYKVLED KIIQEYKKFR
     KQYPSYREEK RRCEYLHQKL SHIKGLILEF EEKNRGS
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2025